Zevra Therapeutics falls after CEO resignation
** Shares of Zevra Therapeutics Inc ZVRA.O down 1.2% at
$4.85
** Richard Pascoe resigns as CEO of the rare disease
therapeutics company, effective June 1
** ZVRA appoints Tamara Favorito as chair of the board
** Board intends to appoint interim-CEO and will immediately
initiate search to identify a new CEO
** ZVRA shares up about 7% YTD
(Reporting by Tanya Jain)
((Tanya.Jain@thomsonreuters.com))
Recent news on Zevra Therapeutics
See all newsZevra Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Zevra Therapeutics Q2 revenue rises 53% on MIPLYFFA sales
Zevra Therapeutics Inc expected to post earnings of 11 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tenet, SLB, Digital Realty
U.S. STOCKS ON THE MOVE-Booz Allen Hamilton, Sensient, Amkor